ReviewCurrent treatment options in oncology2026

Combined Anti-PD-1/PD-L1 and Anti-angiogenic Therapy: An Emerging Direction for Future NSCLC Treatment.

Mingtai Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.